Psychological Well-Being: Clinical Trials

18 trials for Psychological Well-Being, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 2 active not recruiting, 2 recruiting, 1 terminated. 18 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 318Completed 11, Active not recruiting 2, Recruiting 2, Terminated 1, Unknown 1, Withdrawn 1
Phase 22Completed 2

Follow Psychological Well-Being: new trials by email Literature Review of Psychological Well-Being trials Research Report on Psychological Well-Being

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Two Group Experimental Trial Promoting Sports and Exercise Among Female University Students in Saudi Arabia
Counselling sessions - Mental Health
Phase 3Active not recruitingUniversity of Jazan302025-01-012025-03-12
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)
Fasedienol Nasal Spray, Placebo Nasal Spray - Social Anxiety Disorder (SAD)
Phase 3CompletedVistaGen Therapeutics, Inc.2382024-09-162026-11-04
Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering From Gender Dysphoria
hormonal treatment with cross sex hormones (testosterone or oestrogenes) started at 14 years old +/- 6 months, Cross sex hormones ( œstrogenes or testosterone) started at 15.5 years old +/- 6 months - Gender Dysphoria
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris602024-06-252026-08-10
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)
Fasedienol Nasal Spray, Placebo Nasal Spray - Social Anxiety Disorder
Phase 3CompletedVistaGen Therapeutics, Inc.2382024-03-282026-11-03
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
Vitamin D3 Drops, Coriolus Versicolor, Trident SAP 66:33 Lemon - Lung Cancer, Gastric Cancer
Phase 3RecruitingOttawa Hospital Research Institute202022-04-042026-01-30
Homeless Care Management App
In-Person Case Management at Homeless Recovery Program, Unlimited Smartphone, Smartphone Based Case Management (SPCM) app - Substance Use Disorders, Mental Health Impairment
Phase 3CompletedUniversity of Oklahoma4032018-04-272024-12-19
Medical Education Intervention for Medical Students
Education of medical humanities - Mental Health
Phase 3UnknownMing Kuang2002015-12-012016-05-26
VA Augmentation and Switching Treatments for Improving Depression Outcomes
Switching: Bupropion-SR, Augmenting: Antidepressant + Bupropion-SR, Augmenting: Antidepressant + Aripiprazole - Major Depressive Disorder
Phase 3CompletedVA Office of Research and Development15222012-12-012018-05-29
Relaxation for Women With Breast Cancer Undergoing Radiotherapy
Relaxation Program, Questionnaires, Saliva Testing - Breast Cancer
Phase 3Active not recruitingM.D. Anderson Cancer Center6812011-02-102026-10-07
Efficacy of System Constellations in a General Population
system constellations seminar - Psychological Well-being
Phase 2 / Phase 3CompletedHeidelberg University2162011-02-012012-02-09
Mindfulness-based Stress Reduction for Pediatric Mental Health
Mindfulness-based stress reduction program, Usual care - Mental Health Wellness 1
Phase 3CompletedUniversity of Alberta852011-01-012013-12-10
The Effect of Thai Traditional Music on Cognitive Function, Psychological Health and Quality of Sleep Among Thai Older Individuals With Dementia
Music CD - Cognitive Function, Sleep
Phase 3CompletedPhramongkutklao College of Medicine and Hospital602010-02-012011-01-05
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery
Dexmedetomidine, Placebo - Delirium
Phase 3TerminatedHospira, now a wholly owned subsidiary of Pfizer522007-04-012015-07-24
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery
Dexmedetomidine, Placebo - Delirium
Phase 3WithdrawnHospira, now a wholly owned subsidiary of Pfizer2007-04-012017-03-21
Effect of the 'Mother and Baby' Program on Well-Being
Exercise and education, Education - Postnatal Depression
Phase 3CompletedUniversity of Melbourne1602005-07-012008-08-13
Improving Primary Care in Patients With Mental Disorders
Nurse case management, Usual care - Mental Disorders
Phase 3CompletedEmory University4072004-07-012013-11-19
St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
Hypericum perforatum (St. John's wort) - Anxiety Disorders, Mental Health
Phase 2 / Phase 3CompletedNational Center for Complementary and Integrative Health (NCCIH)562002-08-012007-09-26
CAFE Comparison of Atypicals in First Episode of Psychosis
Olanzapine, risperidone - Schizophrenia, Psychotic Disorders
Phase 3CompletedAstraZeneca2002-03-012013-01-04

Narrower conditions

Mental Disorders (4)  ·  Anxiety Disorders (3)  ·  Phobia, Social (3)  ·  Delirium (2)  ·  Motor Activity (2)  ·  Nervous System Diseases (2)  ·  Breast Neoplasms (1)  ·  Dementia (1)  ·  Depression (1)  ·  Depression, Postpartum (1)  ·  Depressive Disorder (1)  ·  Depressive Disorder, Major (1)  ·  Disease (1)  ·  Esophageal Neoplasms (1)

Broader conditions

Behavior (18)  ·  Personal Satisfaction (18)  ·  Mental Disorders (9)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Neurocognitive Disorders (3)  ·  Signs and Symptoms (3)  ·  Confusion (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Nervous System Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Pathologic Processes (2)  ·  Phobic Disorders (2)  ·  Sleep Wake Disorders (2)

Interventions

Dexmedetomidine (2)  ·  Amyloid (1)  ·  Aripiprazole (1)  ·  Curcumin (1)  ·  Educational Status (1)  ·  Exercise (1)  ·  Fish Oils (1)  ·  Hypericum extract LI 160 (1)  ·  Olanzapine (1)  ·  Probiotics (1)  ·  Relaxation Therapy (1)  ·  Risperidone (1)  ·  Standard of Care (1)  ·  Surveys and Questionnaires (1)  ·  Tea (1)

Sponsors

Hospira, now a wholly owned subsidiary of Pfizer (2)  ·  VistaGen Therapeutics, Inc. (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AstraZeneca (1)  ·  Emory University (1)  ·  Heidelberg University (1)  ·  M.D. Anderson Cancer Center (1)  ·  Ming Kuang (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  Ottawa Hospital Research Institute (1)  ·  Phramongkutklao College of Medicine and Hospital (1)  ·  University of Alberta (1)  ·  University of Jazan (1)  ·  University of Melbourne (1)  ·  University of Oklahoma (1)

Countries

United States (10)  ·  Canada (3)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Saudi Arabia (1)  ·  Thailand (1)

Top investigators

Akarachaid Pinidbunjerdkool, MD (1)  ·  Andrew Seely, MD, PhD, FRCSC (1)  ·  Benjamin G. Druss, MD, MPH (1)  ·  Chananya Potisuk (1)  ·  Dugald Seely, ND, MSc (1)  ·  Emily Ashby, BPhysio (1)  ·  Jennifer M Reingle, Ph.D. (1)  ·  Jochen Schweitzer-Rothers, Professor (1)  ·  Kanokporn Wonganankit (1)  ·  Lorenzo Cohen, PHD (1)  ·  Margaret Sherburn, MWHlth (1)  ·  Mary P Galea, PhD (1)  ·  Mathirut Mungthin, MD (1)  ·  Michael S Businelle, Ph.D. (1)

Results publications

PMID 17606657, PMID 17606658, PMID 18312044, PMID 20008945, PMID 20056720, PMID 24251855, PMID 27479536, PMID 28697253, PMID 29871852, PMID 30695291, PMID 30947531, PMID 32603560, PMID 32677243, PMID 33225492, PMID 34246265, PMID 35366613, PMID 37859623, PMID 40742171

NIH funding

2019 (1), R01MD010733 (1), R01MH070437 (1), T32CA009666 (1)